Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia
Condition:   Leukemia Intervention:   Biological: IM19 CAR-T cells Sponsor:   Beijing Immunochina Medical Science& Technology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2022 Category: Research Source Type: clinical trials

Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms
Conditions:   Advanced Solid Tumors;   Digestive System Neoplasms;   Pancreatic Cancer Resectable;   Colorectal (Colon or Rectal) Cancer Intervention:   Drug: IM96 CAR-T cells Sponsor:   Beijing Immunochina Medical Science& Technology Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2022 Category: Research Source Type: clinical trials